Story
J&J Talc Lawsuits Face Potential Dismissal After Judge Questions Cancer Evidence
Summary
A federal judge has cast significant doubt on the scientific evidence in thousands of lawsuits alleging Johnson & Johnson's talc products caused ovarian cancer, ordering plaintiffs to provide more specific proof. This development could lead to the dismissal of approximately 69,000 cases consolidated in a New Jersey court.
A U.S. federal judge has questioned the validity of claims in approximately 69,000 lawsuits alleging that Johnson & Johnson's talc products caused ovarian cancer, a move that could jeopardize the massive litigation against the healthcare giant. The judge stated that plaintiffs must provide more specific evidence linking the products to their cancer or face potential dismissal of their cases.
Judge Cites Expert Testimony
In an opinion issued Wednesday, U.S. Magistrate Judge Rukhsanah Singh in Trenton, New Jersey, highlighted recent testimony from two expert witnesses for the plaintiffs, Judith Wolf and Daniel Clarke-Pearson. According to the judge, the experts testified in May that they could not definitively rule out other potential causes for the plaintiffs' ovarian cancer.
Judge Singh wrote that this testimony raises doubts about whether any plaintiff can present court-admissible evidence proving "that talcum powder use specifically caused her ovarian cancer." The judge questioned how plaintiffs could meet their legal burden of proof given this uncertainty, writing, "If such uncertainty is indeed reality, then how can any plaintiff here meet her burden on the merits of her claim?"
Implications for Litigation
The ruling is a significant development in the consolidated federal litigation against J&J. The expert testimony was part of preparations for a series of "bellwether" trials, which are used as test cases to help guide settlement negotiations for the thousands of remaining lawsuits.
AdWhile Judge Singh noted the issue would not lead to an "instant dismissal" of the cases, she has ordered the plaintiffs to respond by November 19. They must explain why their lawsuits should not be dismissed for failing to provide an admissible expert opinion on the specific cause of their cancer.
Context and Company Position
Johnson & Johnson has consistently denied allegations that its talc products, including its iconic Baby Powder, are carcinogenic. The company has maintained that decades of scientific studies show the products are safe and do not contain asbestos.
A lead attorney for the plaintiffs and a spokesperson for Johnson & Johnson did not immediately respond to a request for comment on the ruling, according to Reuters. The decision marks a critical juncture in one of the largest mass tort litigations in U.S. history.
Read next
More on Stocks
Indian Insurance Stocks Plunge on Proposed Overhaul of Commission Rules
Shares of Indian insurance and fintech companies fell sharply after the country's regulator proposed a significant overhaul of commission structures, which could cap payouts to agents and distributors.
Capricorn Energy Lifts Output Forecast Amid Competing Takeover Bids
Capricorn Energy raised its full-year production forecast, citing strong performance from its Egyptian assets, as it continues to evaluate competing takeover offers from DNO and Genel Energy.
Honda Plans Up to $2.5 Billion Hybrid Vehicle Plant in Ohio, Nikkei Reports
The Japanese automaker is reportedly in the final stages of planning a new facility with an investment of up to ¥400 billion ($2.53 billion) to meet rising consumer demand for hybrid models in North America.
JPMorgan Appoints Francesco Lavatelli to Lead Japan Operations
JPMorgan has named Francesco Lavatelli as its new senior country officer for Japan, effective Dec. 1, as part of a leadership shuffle that sees former head Steve Rinoie move into a global role.